The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
Finds that the 3 large PBMs jack up the price of low cost generic PrEP by over 1000% for commercial markets and medicare.
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
www.ftc.gov
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty g
Health Insurers Must Cover All PreP:
Glassman: How Trump can meet his goal of ending AIDS
www.bostonherald.com
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States within 10 years” by launching the federal Ending the HIV Epidemic I...
What STAT readers thought went overlooked in 2024: "The Biden admin’s failure to enforce a 2023 U.S. District Court for the District of Columbia ruling that struck down a Trump-era rule allowing #insurers to implement #copayaccumulator progs":
Long Covid, AI ‘obsession,’ trust: What STAT readers thought went overlooked in 2024
bit.ly
Long Covid, AI, and trust: STAT readers on what went underdiscussed in 2024 — and what they think will happen in 2025.
In a new Chicago Sun-Times opinion, leaders at the HIV and Hepatitis Policy Institute & Diabetes Leadership Council underscore the need for the 119th Congress to pass comprehensive #PBM reform to ensure that all #patients, regardless of disease progression or diagnosis, can access the care they rely on. Read more: bit.ly/CST-PBMs